Nonprofit seeks COVID-19 vaccines for most vulnerable

By The Science Advisory Board staff writers

April 24, 2020 -- The nonprofit consortium Human Vaccines Project has launched an initiative to ensure COVID-19 vaccines are developed for vulnerable populations.

Its COVID Vaccine Initiative (CVI) will focus on accelerating vaccine development for aging populations and those living in countries with low and middle incomes. Founding partners include FHI 360 and the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota.

The initiative's research and development program will use immune monitoring, systems biology, and artificial intelligence to conduct studies to determine how to generate effective immunity in these populations.

The advocacy and policy program aims to disseminate critical information and data relevant to accelerating vaccine development. The CVI will produce weekly reports and host a bi-weekly Global Lab Meeting beginning in May 2020 to bring the scientific community together. It will develop a roadmap to ensure research and development challenges are addressed.

COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...
Integral Molecular wins COVID-19 NIAID award
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Integral Molecular $1 million to help discover vaccines and therapeutics...
MilliporeSigma, Jenner Institute partner on COVID-19 vaccine
MilliporeSigma and the Jenner Institute have announced that they are preparing for large-scale manufacturing of the COVID-19 vaccine candidate ChAdOx1...
Could a MERS vaccine candidate be the answer for COVID-19?
As researchers urgently work to develop vaccines to prevent COVID-19, many strategies have been considered. Now, a parainfluenza virus 5-based vaccine...
Pfizer, BioNTech give details about mRNA COVID-19 vaccine deal
Biopharmaceutical New Technologies (BioNTech) and Pfizer have released additional details regarding their collaboration to advance the mRNA COVID-19 vaccine...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter